Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of liquid biopsy in breast cancer: A systematic review.

Clinical genetics - 1 Mar 2022

Duque Galo, Manterola Carlos, Otzen Tamara, Arias Cristina, Galindo Bryan, Mora Miriann, Guerrero Enmanuel, García Nayeli

Abstract excerpt

Advancements in genetic sequencing techniques along with the identification of specific mutations and structural changes in multiple cancer genes, make it possible to identify circulating tumor cells and cell free nucleic acids as blood-based biomarkers, serving as a liquid biopsy (LB) with great utility for the diagnosis, treatment and follow-up of patients with neoplasms. This systematic review focuses on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Liquid Biopsy

Share to Mutation

Source

Identifiers

PMID: 34687555
DOI: 10.1111/cge.14077

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of liquid biopsy in breast cancer: A systematic review.PMID 34687555Read ↗

Liquid Biopsy in Breast Cancer: A Focused Review.Semantic proximity Read ↗

[Current situation and prospect of breast cancer liquid biopsy].Semantic proximity Read ↗

Liquid biopsy in early breast cancer. A preliminary reportSemantic proximity Read ↗

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read ↗

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity Read ↗

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.Semantic proximity Read ↗

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity Read ↗

The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Semantic proximity Read ↗

Early-Stage Breast Cancer Detection in Breast Milk.Semantic proximity Read ↗

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.